Cyril Sobolewski

2.6k total citations · 1 hit paper
34 papers, 2.0k citations indexed

About

Cyril Sobolewski is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Cyril Sobolewski has authored 34 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Cancer Research and 7 papers in Pharmacology. Recurrent topics in Cyril Sobolewski's work include RNA modifications and cancer (14 papers), MicroRNA in disease regulation (12 papers) and Cancer-related molecular mechanisms research (9 papers). Cyril Sobolewski is often cited by papers focused on RNA modifications and cancer (14 papers), MicroRNA in disease regulation (12 papers) and Cancer-related molecular mechanisms research (9 papers). Cyril Sobolewski collaborates with scholars based in Switzerland, United States and Luxembourg. Cyril Sobolewski's co-authors include Michelangelo Foti, Dobrochna Dolicka, Marta Correia de Sousa, Monika Gjorgjieva, Claudia Cerella, Mario Dicato, Marc Diederich, Lina Ghibelli, Nicolas Calo and Dan A. Dixon and has published in prestigious journals such as Gut, Scientific Reports and The FASEB Journal.

In The Last Decade

Cyril Sobolewski

33 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deciphering miRNAs’ Action through miRNA Editing

2019 624 citations Marta Correia de Sousa, Monika Gjorgjieva et al. profile →

Peers

Cyril Sobolewski

EPIDE

PHARM

IMMUN

Nan Wu China

Min Ma China

Qing Tang China

Yang Jiao China

Ling Xu China

Mahmoud Aghaei Iran

Qinghua Lu China

Chang Han United States

Chun‐Yin Huang Taiwan

Nan Wu China

Cyril Sobolewski

1.5k ×1.3

915 ×1.0

265 ×0.7

EPIDE

150 ×0.6

PHARM

251 ×1.6

IMMUN

Citations per year, relative to Cyril Sobolewski Cyril Sobolewski (= 1×) peers Nan Wu

Countries citing papers authored by Cyril Sobolewski

Since Specialization

Citations

This map shows the geographic impact of Cyril Sobolewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Sobolewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Sobolewski more than expected).

Fields of papers citing papers by Cyril Sobolewski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Sobolewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Sobolewski. The network helps show where Cyril Sobolewski may publish in the future.

Co-authorship network of co-authors of Cyril Sobolewski

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Sobolewski. A scholar is included among the top collaborators of Cyril Sobolewski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Sobolewski. Cyril Sobolewski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gjorgjieva, Monika, Nicolas Calo, Cyril Sobolewski, et al.. (2024). Hepatic IR and IGF1R signaling govern distinct metabolic and carcinogenic processes upon PTEN deficiency in the liver. JHEP Reports. 7(4). 101305–101305. 4 indexed citations

Carpentier, Rodolphe, et al.. (2023). MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?. Cancers. 15(23). 5557–5557. 8 indexed citations

Sobolewski, Cyril, Étienne Lefai, Dulce Alfaiate, et al.. (2023). ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance. Scientific Reports. 13(1). 6767–6767. 1 indexed citations

Sobolewski, Cyril, Alexandre Lüscher, Matthew Bacchetta, et al.. (2023). Targeting HuR-Vav3 mRNA interaction prevents Pseudomonas aeruginosa adhesion to the cystic fibrosis airway epithelium. JCI Insight. 8(3). 2 indexed citations

Gjorgjieva, Monika, Anne‐Sophie Ay, Marta Correia de Sousa, et al.. (2022). MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver. Cells. 11(18). 2860–2860. 5 indexed citations

Fröhlich, Jan, Tommaso Mazza, Cyril Sobolewski, Michelangelo Foti, & Manlio Vinciguerra. (2021). GDF11 rapidly increases lipid accumulation in liver cancer cells through ALK5-dependent signaling. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(6). 158920–158920. 19 indexed citations

Sousa, Marta Correia de, Nicolas Calo, Cyril Sobolewski, et al.. (2021). Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis. Cancers. 13(19). 4983–4983. 24 indexed citations

Sobolewski, Cyril, Daniel Abegg, Flavien Berthou, et al.. (2020). S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut. 69(10). 1841–1854. 62 indexed citations

Dolicka, Dobrochna, Cyril Sobolewski, Monika Gjorgjieva, et al.. (2020). Tristetraprolin Promotes Hepatic Inflammation and Tumor Initiation but Restrains Cancer Progression to Malignancy. Cellular and Molecular Gastroenterology and Hepatology. 11(2). 597–621. 11 indexed citations

10.

Fröhlich, Jan, Tommaso Mazza, Maria Rita Emma, et al.. (2020). GDF11 induces mild hepatic fibrosis independent of metabolic health. Aging. 12(20). 20024–20046. 17 indexed citations

11.

Dixon, Dan A., et al.. (2020). Stress granules in colorectal cancer: Current knowledge and potential therapeutic applications. World Journal of Gastroenterology. 26(35). 5223–5247. 21 indexed citations

12.

Gjorgjieva, Monika, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, & Michelangelo Foti. (2019). miRNAs and NAFLD: from pathophysiology to therapy. Gut. 68(11). 2065–2079. 185 indexed citations

13.

Dixon, Dan A., et al.. (2019). AU-rich element-binding proteins in colorectal cancer. World Journal of Gastrointestinal Oncology. 11(2). 71–90. 20 indexed citations

14.

Calo, Nicolas, Pierluigi Ramadori, Cyril Sobolewski, et al.. (2016). Stress-activated miR-21/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption. Gut. 65(11). 1871–1881. 105 indexed citations

15.

Sobolewski, Cyril, et al.. (2016). Hepatitis C Virus Core Protein of Genotype 3A Downregulates PTEN Expression in Hepatocytes through Micrornas-Dependent Mechanisms. Journal of Hepatology. 64(2). S423–S423.

16.

Sobolewski, Cyril, Florian L. Müller, Claudia Cerella, et al.. (2015). 2,5-Dimethyl-Celecoxib Inhibits Cell Cycle Progression and Induces Apoptosis in Human Leukemia Cells. Journal of Pharmacology and Experimental Therapeutics. 355(2). 308–328. 21 indexed citations

17.

Sobolewski, Cyril, Florian L. Müller, Claudia Cerella, Mario Dicato, & Marc Diederich. (2014). Celecoxib prevents curcumin‐induced apoptosis in a hematopoietic cancer cell model. Molecular Carcinogenesis. 54(10). 999–1013. 9 indexed citations

18.

Cerella, Claudia, Cyril Sobolewski, Sébastien Chateauvieux, et al.. (2011). COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells. Biochemical Pharmacology. 82(10). 1277–1290. 20 indexed citations

19.

Sobolewski, Cyril, Claudia Cerella, Mario Dicato, & Marc Diederich. (2011). Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells. Cell Cycle. 10(17). 2978–2993. 22 indexed citations

20.

Cerella, Claudia, Cyril Sobolewski, Mario Dicato, & Marc Diederich. (2010). Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy. Biochemical Pharmacology. 80(12). 1801–1815. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact